In addition to having anti-inflammatory properties, substances called amorfrutins from the licorice plant’s root have now been found to reduce blood sugar levels in mice.
A researcher hoping to one day take away the need for needles in diabetes care has been recognised at the latest WA Innovator of the
Novo Nordisk’s FlexTouch is the latest advancement in pre-filled insulin pens. Designed to help improve patients’ experience of daily insulin injections, the unique design of
As well as having diabetes, if you also have high cholesterol then your risk of developing cardiovascular disease, which is the UK’s biggest killer is
Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals have announced that they will be working together to fund a series of clinical studies testing the use
Sanofi-Aventis said that lixisenatide, an experimental Type 2 diabetes drug, has been very successful in a late stage trial at helping patients reduce their blood
GlaxoSmithKline says that Otelixizumab, a Type 1 drug currently under development, has failed in a phase III clinical trial. The drug has been in development
Research recently published in the The Lancet has indicated that early studies into a new basal insulin option for people with type 2 diabetes, which
EU-funded scientists say they have genetic proof of how a commonly used diabetes drug works for patient treatment. On a global scale, the drug metformin
Drugmaker Merck is buying privately held company SmartCells, which is developing an experimental form of “intelligent insulin,” according to a recent article from the Financial
